(Q47241156)

12 January 2018

title

Marked weight reduction lowers resting and exercise blood pressure in morbidly obese subjects (English)

1 reference

12 January 2018

author

Ehud Grossman

2

1 reference

12 January 2018

author name string

Ben-Dov I

1

1 reference

12 January 2018

Stein A

3

1 reference

12 January 2018

Shachor D

4

1 reference

12 January 2018

Gaides M

5

1 reference

12 January 2018

publication date

1 March 2000

1 reference

12 January 2018

Journal of Clinical Hypertension

published in

1 reference

12 January 2018

volume

13

1 reference

12 January 2018

issue

3

1 reference

12 January 2018

page(s)

251-255

1 reference

12 January 2018

Therapy-resistant hypertension associated with central obesity, insulin resistance, and large muscle fibre area

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Obesity, glucose intolerance, hyperinsulinemia, and response to antihypertensive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Effect of Weight Loss without Salt Restriction on the Reduction of Blood Pressure in Overweight Hypertensive Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Body weight and blood pressure. Effects of weight reduction on hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Relationship of co-morbidities of obesity to weight loss and four-year weight maintenance/rebound

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Prognostic significance of exercise blood pressure and heart rate in middle-aged men

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Left ventricular hypertrophy in men with normal blood pressure: relation to exaggerated blood pressure response to exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Exercise systolic blood pressure: a powerful determinant of increased left ventricular mass in patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Influence of work rate on ventilatory and gas exchange kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Significant changes in blood pressure, glucose, and lipids with gastric bypass surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Disparate cardiovascular response to stress tests during isradipine and fosinopril therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Blood pressure and hormone changes associated with weight reduction in the obese

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Role of sympathetic activity in blood pressure reduction with low calorie regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Obesity, the sympathetic nervous system, and essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Role of insulin and norepinephrine in the hypertension of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Role of the sympathetic nervous system in blood pressure maintenance in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Regional hemodynamic abnormalities in overweight men. Focus on alpha-adrenergic vascular responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Relation of obesity and diet to sympathetic nervous system activity

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Effect of energy-restricted diet on sympathetic muscle nerve activity in obese women

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Fasting, Feeding and Regulation of the Sympathetic Nervous System

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Body weight and blood pressure regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Obesity and hypertension. Demonstration of a "floor effect"

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Impact of gastric restrictive surgery on hypertension in the morbidly obese

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

The effect of gastric bypass surgery on hypertension in morbidly obese patients

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Antihypertensive effect of diet compared with drug treatment in obese men with mild hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

Hypocaloric diet and antihypertensive drug treatment. A randomized controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2899%2900190-9

7 January 2021

10.1016/S0895-7061(99)00190-9

Identifiers

DOI

1 reference

12 January 2018

PubMed ID

10777028

1 reference

12 January 2018